Imagine a day when joints could heal themselves.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045
Head and Neck Cancer Cancer Squamous Cell Carcinoma
Researchers at the University of Colorado Anschutz Medical Campus studying interactions between nerves and tumor microenvironments have found that commonly used drugs like botox may stop or slow the progression of certain head and neck cancers.
Research Drug Development Quantum
Although a search for “quantum” in the popular media turns up mostly references to a revived TV series (“Quantum Leap”) and a recent superhero film (“Quantumania”), in the science world, the actual technology is creating quite the buzz.
When immune systems go awry, they can wreak havoc, triggering everything from diabetes to – scientists now believe – Alzheimer’s disease (AD). But immune systems are supposed to protect, not injure, the body. So what if scientists could pinpoint a window before things go amiss and harness the defense system in a way that curbs or prevents AD from taking hold?
Seventy BS in Nursing students at Anschutz Medical Campus had a unique opportunity to get hands-on experience during their clinicals at an assisted living community for their Nursing Care of the Older Adult course.
Researchers have identified a protein that, when targeted, enables cisplatin-resistant cancer cells to become responsive to treatment. Cisplatin, and other similar platinum drugs, are incredibly effective at killing rapidly growing cancer cells, which is why they have been used in treating cancers for over 45 years. However, these drugs are non-targeted and can cause debilitating toxic side effects, resulting in a diminished lifestyle, and patients in poor health are deemed ineligible for use.
Feeling déjà vu watching coverage of this year’s presidential election? You’re not alone. Below, Steven Berkowitz, MD, professor of psychiatry at the University of Colorado School of Medicine, talks about how this feeling of repetition can cause apathy, dread or general media burnout – and how important it is to stay involved.
Daisy Espino Aguilar, a BS in Nursing student at the University of Colorado College of Nursing at Anschutz Medical Campus recently returned from a clinical immersion experience in Guatemala. She went to Guatemala with eight other students in the BS in Nursing Traditional (TRAD) Program for 13 days in February.
The CU Skaggs School of Pharmacy and Pharmaceutical Sciences is thrilled to introduce Blake Hill, PhD, as Chair of the Department of Pharmaceutical Sciences (DOPS). Dr. Hill’s passion for making a difference in health, coupled with an eagerness to face the challenges posed by environmental and climate-induced changes, will propel the Department of Pharmaceutical Sciences to new heights at CU Pharmacy.
Neuroscience Pharmaceutical Sciences Alzheimer's
The health impacts of a complex protein that plays a major role in the development of Alzheimer’s disease and heart conditions can be lessened by three kinds of drug inhibitors, according to scientists at the University of Colorado Anschutz Medical Campus.
Conversation article by Brian Strickland, MD, Senior Instructor in Emergency Medicine, University of Colorado Anschutz Medical Campus
“The Injury and Violence Prevention Center is pleased to support the Office of Gun Violence Prevention in the continual advancement of the resource bank,” said Ashley Brooks-Russell, PhD, director of the Injury and Violence Prevention Center in the release. It describes the effort as a collaborative initiative of the Colorado School of Public Health and the University of Colorado School of Medicine at the CU Anschutz Medical Campus.
This suggests “that bariatric surgery is an effective intervention for better diabetes management, but the effects are not as sustainable as one had hoped for,” Neda Rasouli, MD, Diabetes and Endocrinology Clinical Trial Program director at the University of Colorado School of Medicine, said in an email. She was not involved in the study.
Gregory G. Schwartz, MD, PhD, chief of the cardiology section at Rocky Mountain Regional VA Medical Center and professor of medicine at the University of Colorado School of Medicine in Aurora, Colorado, is leading the VA-IMPACT trial. Despite metformin's long history and widespread use, he said his study is the first placebo-controlled cardiovascular outcomes trial of the drug.
13001 East 17th Place
Aurora, CO 80045
303-724-9290
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.